Skip to content
HowShorted

PMV Pharmaceuticals, Inc. short interest in 2021

In 2021, PMV Pharmaceuticals, Inc.'s disclosed short interest ran from 3.98% of shares outstanding on 15 Jan 2021 to 8.16% on 31 Dec 2021, a change of +4.18 percentage points. The year's high was 8.16% on 31 Dec 2021 and its low 3.52% on 29 Jan 2021, averaging 6.14% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.56 days on 30 Apr 2021. Full history: PMV Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for PMV Pharmaceuticals, Inc. in 2021

2021 in figures

Start of year
3.98% (15 Jan 2021)
End of year
8.16% (31 Dec 2021)
Change
+4.18 pp
High
8.16% (31 Dec 2021)
Low
3.52% (29 Jan 2021)
Average
6.14%
Highest days to cover
27.56 (30 Apr 2021)
SEC filings marked
8

Every report in 2021

PMV Pharmaceuticals, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20213.98%15.67
29 Jan 20213.52%23.04
12 Feb 20213.63%16.18
26 Feb 20213.90%23.85
15 Mar 20214.04%21.5810-K filed, results (8-K)
31 Mar 20216.26%8.48
15 Apr 20217.37%16.17
30 Apr 20217.60%27.56
14 May 20217.33%16.1010-Q filed, results (8-K)
28 May 20217.66%14.68
15 Jun 20217.40%14.59
30 Jun 20217.27%5.54
15 Jul 20216.84%9.93
30 Jul 20216.60%7.93
13 Aug 20216.35%7.1610-Q filed, results (8-K)
31 Aug 20216.24%7.96
15 Sep 20215.09%6.11
30 Sep 20216.66%5.79
15 Oct 20216.46%8.64
29 Oct 20216.36%13.09
15 Nov 20215.96%7.8010-Q filed, results (8-K)
30 Nov 20215.91%7.24
15 Dec 20216.89%5.15
31 Dec 20218.16%7.00

See also: PMV Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.